硬化素:常染色体显性多囊肾病领域的新面孔?
本研究为观察性横断面研究,纳入100例终末期肾病患者,比较常染色体显性多囊肾病(ADPKD)与其他原发性肾病患者循环硬化素水平。结果显示ADPKD患者硬化素水平更高、骨特异性碱性磷酸酶(BALP)更低,且多变量分析中ADPKD与硬化素水平独立相关。提示ADPKD中硬化素升高可能反映机械感受受损,其临床意义待研究。
要点
- ADPKD患者循环硬化素水平高于其他原发性肾病患者。
- ADPKD患者骨特异性碱性磷酸酶水平低于其他原发性肾病患者。
- ADPKD与硬化素水平的关联独立于年龄、性别、BMI、糖尿病、磷酸盐、PTH和1,25(OH)2D。
核心结论
- 常染色体显性多囊肾病(ADPKD)患者循环硬化素水平升高,可能反映机械感受受损。
- 该发现的临床意义尤其是对骨健康的影响尚待研究。
研究设计与样本
- 观察性横断面研究,纳入100例终末期肾病患者,来自瑞典斯德哥尔摩一项正在进行的纵向队列研究。
- 检测循环硬化素及矿物质骨病相关实验室指标,包括全段甲状旁腺激素(PTH)、钙、磷酸盐、镁、25(OH)维生素D、1,25(OH)2维生素D和骨特异性碱性磷酸酶(BALP)。
主要发现
- ADPKD患者较其他原发性肾病患者硬化素水平更高、BALP水平更低。
- 多变量分析中,ADPKD与循环硬化素水平相关,独立于年龄、性别、体重指数、糖尿病、磷酸盐、PTH和1,25(OH)2维生素D等既定决定因素。
临床怎么用
- 在评估肾衰竭相关矿物质骨病时,需考虑肾脏病病因(如ADPKD)这一潜在混杂因素。
局限性
- 为横断面观察性研究,无法推断因果关系。
- 研究仅纳入终末期肾病患者,结论不能外推至早期ADPKD人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease originating from a mutation in genes encoding polycystin 1 and 2. Recent evidence suggests that these polycystins mediate mechanosensation not only in the primary cilium of kidney cells but also in bone cells. The Wnt/β-catenin signaling pathway plays a central role in mechanotransduction in osteocytes. Mechanical unloading causes the upregulation of the Wnt inhibitor sclerostin. We tested the hypothesis that ADPKD associates with higher circulating sclerostin levels. METHODS: In this observational, cross-sectional study, circulating levels of sclerostin and other laboratory parameters of mineral and bone disease, including intact parathyroid hormone (PTH), calcium, phosphate, magnesium, 25(OH) D-vitamin, 1,25 (OH)2 D-vitamin, and bone specific alkaline phosphatase (BALP) were assessed in 100 patients with end-stage renal disease recruited from an ongoing longitudinal cohort study in Stockholm, Sweden. RESULTS: Patients with ADPKD had higher sclerostin levels and lower BALP levels as compared to patients with other primary renal disease. In multivariate analysis, ADPKD associated with circulating sclerostin levels, independent of the established determinants including age, gender, body mass index, diabetes, phosphate, PTH, and 1,25 (OH)2 D-vitamin. DISCUSSION: Circulating sclerostin levels are increased in ADPKD, possibly reflecting impaired mechanosensation. The clinical relevance of this finding, especially with regard to bone health, remains to be investigated. Our finding draws attention to the etiology of kidney disease as an important, yet neglected, confounder of the association between renal failure and mineral and bone disease.
引用
- Jankowska M, Haarhaus M, Qureshi AR, et al. Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene? Kidney Int Rep. 2017. PMID: 29142975. doi:10.1016/j.ekir.2017.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。